Jasminka M. A.
- Country
- Croatia
- Department
- HR10002
Research Overview
- Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- A Pharmacokinetic and Safety Study of Bimekizumab via Different Routes of Administration in Adults with Chronic Cutaneous Inflammation
Data & Insights
Has run more than one trial at 178 of 315 partner sites.
Specializations
Autoimmune Arthritis
The investigator specializes in the treatment of psoriatic arthritis, particularly focusing on innovative therapeutic approaches for patients who have not previously received biologic disease-modifying antirheumatic drugs (DMARDs).
- Novel therapeutic agents
- Biologic-naive patient populations
- Treatment response assessment
Research activities concentrate on evaluating emerging treatments including sonelokimab and zasocitinib for managing active psoriatic arthritis.
Connective Tissue Disorders
The investigator conducts research in systemic sclerosis treatment, with particular attention to innovative subcutaneous therapies targeting skin sclerosis manifestations.
- Skin sclerosis management
- Subcutaneous administration methods
- Novel biological therapies
Current research focuses on evaluating efgartigimod PH20 SC as a potential treatment option for systemic sclerosis patients.
Systemic Autoimmune Conditions
The investigator explores treatments for Sjögren's Syndrome, with emphasis on addressing both general manifestations and moderate-to-severe systemic disease activity.
- Systemic disease management
- Long-term safety evaluation
- Symptom control strategies
Research efforts center on investigating dazodalibep for treating various presentations of Sjögren's Syndrome.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.